Tag Archives: EU

Saving Greece's Healthcare System: A Harbinger for Europe?

A just-published report from the European taskforce trying to help Greece crawl out of its crisis makes clear just how significant a role health reform is supposed to play in restoring health to the economy. It is, in a very acute form, a harbinger of what is around the corner for the other countries of [...]
Posted in Europe, Global, Guest Blog, healthcare | Also tagged , , , , , | Leave a comment

Thinking of Phase IV Trials? Europe Might See Things Differently…

By Peter O’ Donnell. With the shadow cast by Mediator across Europe now receding to a focus on the French law courts, the European Union (EU) said in late November that its pharmacovigilance arrangements offer “one of the most advanced and comprehensive systems in the world”. Certainly the EU’s legislative framework has been significantly boosted over [...]
Posted in Europe, Global, Guest Blog, R&D | Also tagged , , , | Leave a comment

European Pharma Bets on Greek Salvation

The French philosopher Pascal calculated that it was better to believe in God than to disbelieve. After offering the country a €2.88 billion cap on drug spending, it looks like European pharma is taking that view with regard to Greece. Reflector reports. The European pharma industry looks like it is accepting Pascal’s Wager in Greece. It [...]
Posted in Europe, Global, Guest Blog | Also tagged , , , , , | Leave a comment

EFPIA Calls for New Deal in Europe

EFPIA president Andrew Witty is hoping that the deepening European economic crisis will impel European leaders towards more courageous and radical solutions, writes Reflector. With the European economic and financial crisis deepening all the time, the healthcare sector in general — and the pharmaceutical sector in particular — faces further constraints from cost cutting. As European [...]
Posted in Europe, Guest Blog, Op-Ed, Regulatory, healthcare | Also tagged , , , , , | Leave a comment

European Pharma 1981-2011: Survival of the Fittest?

This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, IP, Pharm Exec Magazine, R&D, Regulatory, healthcare, leadership | Also tagged , , , , , | Leave a comment